Community Engagement and Dissemination Core

摘要：社区参与和传播的核心 我们的社区参与和传播核心的目标是培育和传播创新的 研究在认知障碍的交叉点，痴呆症，和阿尔茨海默病在精密 医学框架，告知个性化的预防，诊断和治疗以后的生活。两个不同的，但是 相关战略是我们实现这一目标的方法的特点。第一个战略是加强现有的 合作，并建立新的与原住民病人倡导团体，部落社区和他们的 印度卫生服务、部落和城市卫生保健系统的领导人、提供者和管理人员 （I/T/U），美国印第安人/阿拉斯加原住民（AI/AN）健康的政策制定者，以及其他研究密集型 高校第二项战略认识到，只有在以下情况下，健康研究才能使患者和社区受益： 科学家和卫生专业人员使用有效的方式在社区环境中交流新的发现 and into clinical临床practices实践.我们的工作将通过创新和传统渠道进行， 为预防、诊断和治疗提供更精确方法的信息和干预措施 认知障碍，痴呆症和阿尔茨海默病在整个AI/AN社区。因此 具体目标是：1）重新配置和扩大与私人，部落和 公共选区包括认知障碍，痴呆症和阿尔茨海默氏症的经验驱动的重点 精准医学框架内的疾病; 2）制定多层次，多部门，经验驱动的 基础设施和相关进程，确保纳入地方、区域和国家优先事项， 在较老的AI/AN中，针对该议程的精准医学研究议程的方法; 3）传播 向科学界提供中心研究项目和试点项目的成果，以鼓励新的研究 AI/AN社区和研究人员之间的合作;以及4）传播中心研究的结果 为AI/AN患者提供护理的卫生专业人员社区的项目和试点项目， 社区通过使用现代科学的实施方法来影响实践的变化。社区 参与和传播核心将由Denise Dillard，博士（Inupiat），Southcentral基金会领导， Meghan Jernigan，公共卫生硕士，本土健康合作伙伴，华盛顿州立大学。他们将负责 规划、协调和实施核心活动，包括预算编制、人员监督 预约、空间分配以及项目管理和运营的其他方面。支持 行政核心，这些活动将与RP董事曼森博士和纳尔逊博士协同进行， 和中心执行委员会。有文化针对性的参与和传播将发挥关键作用 在采用更精确的方法来预防，检测和治疗认知障碍，痴呆症， 和老年痴呆症之间的关系我们在原住民社区工作的40年大大提高了我们的 传播新知识和新方法的能力，以改善这一特殊人群的此类问题。

Abstract: Community Engagement and Dissemination Core The goal of our Community Engagement and Dissemination Core is to nurture and disseminate innovative research at the intersection of cognitive impairment, dementia, and Alzheimer's Disease within a Precision Medicine framework that informs personalized prevention, diagnosis, and treatment later in life. Two distinct, but related strategies characterize our approach to achieving this goal. The first strategy strengthens current collaborations and establishes new ones with Native patient advocacy groups, tribal communities and their leaders, providers and administrators in the Indian Health Service, tribal, and urban Indian health care system (I/T/U), policymakers in American Indian/Alaska Native (AI/AN) health, and with other research intensive universities. The second strategy recognizes that health research benefits patients and communities only if scientists and health professionals use effective ways to communicate new findings across community settings and into clinical practices. Our work will proceed using both innovative and traditional channels to disseminate information and interventions that inform more precise approaches to preventing, diagnosing, and treating cognitive impairment, dementia, and Alzheimer's Disease throughout AI/AN communities. Accordingly, the specific aims are to: 1) reconfigure and expand collaborations with research partners across private, tribal, and public constituencies to include an empirically driven focus on cognitive impairment, dementia, and Alzheimer's Disease within a Precision Medicine framework; 2) develop a multi-level, multi-sector, empirically driven infrastructure and related processes that ensure inclusion of local, regional, as well as national priorities for and approaches to a Precision Medicine research agenda specific to this agenda among older AI/ANs; 3) disseminate the results of Center Research Projects and Pilot Projects to the scientific community to encourage new research collaborations between AI/AN communities and researchers; and 4) disseminate the results of Center Research Projects and Pilot Projects to the communities of health professionals providing care for AI/AN patients and communities by using modern methods of implementation science to affect practice change. The Community Engagement and Dissemination Core will be led by Denise Dillard, PhD (Inupiat), Southcentral Foundation, and Meghan Jernigan, MPH, Partners for Native Health, Washington State University. They will be responsible for planning, coordinating, and implementing Core activities, including budget preparation, oversight of personnel appointments, space allocation, and other aspects of program management and operation. Supported by the Administrative Core, these activities will be carried out in concert with the Drs. Manson and Nelson, RP directors, and the Center Executive Committee. Culturally tailored engagement and dissemination will play a critical role in the adoption of more precise approaches to preventing, detecting, and treating cognitive impairment, dementia and Alzheimer's Disease among AI/ANs. Our 40 years at work in Native communities significantly enhances our ability to disseminate new knowledge and approaches to ameliorating such problems in this special population.